Tele: 561.316.3330
Breaking Medical Device News

Friday, October 15, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeSeelos Therapeutics Inc.

Seelos Therapeutics Inc.

Seelos Therapeutics Announces a Strategic Device Partnership with AptarGroup, Inc.

Strategic Device Partnership Allows Seelos to Use Aptar Pharma's Bidose (BDS) Liquid System Device with the SLS-002 Program (Intranasal Racemic Ketamine). Covers the Use of the BDS Liquid System for Intranasal Delivery of SLS-002 for the Treatment of Suicidality, Major Depressive Disorder and PTSD, and Agreement Provides Other Rights to Include Additional Undisclosed Indications

By using this website you agree to accept Medical Device News Magazine Privacy Policy